Cover Image
市場調查報告書

細胞培養市場分析:各消耗品、各產品、各用途、各市場區隔的預測

Cell Culture Market Analysis By Consumables (Media, Sera, Reagents), By Products (Culture Systems, Incubators, Pipetting Instruments, Centrifuges, Biosafety Equipment, Cryostorage Equipment), By Application And Segment Forecasts To 2022

出版商 Grand View Research, Inc. 商品編碼 530128
出版日期 內容資訊 英文 89 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
細胞培養市場分析:各消耗品、各產品、各用途、各市場區隔的預測 Cell Culture Market Analysis By Consumables (Media, Sera, Reagents), By Products (Culture Systems, Incubators, Pipetting Instruments, Centrifuges, Biosafety Equipment, Cryostorage Equipment), By Application And Segment Forecasts To 2022
出版日期: 2016年02月16日 內容資訊: 英文 89 Pages
簡介

本報告提供全球細胞培養市場相關調查分析,市場概要,各市場區隔的市場預測,競爭情形,主要企業等相關的系統性資訊。

第1章 調查手法、範圍

第2章 摘要整理

第3章 細胞培養產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場動態
  • 主要的機會
  • 波特的五力分析
  • PESTEL分析

第4章 細胞培養市場:各消耗品預測

  • 各消耗品
  • 血清
  • 試劑
  • 培養基

第5章 細胞培養市場:各產品預測

  • 各產品
  • 培養系統
  • 培養器
  • 離心機
  • 低溫貯存設備
  • 生物安全性設備
  • 分注設備

第6章 細胞培養市場:各用途預測

  • 各用途
  • 生物醫藥品

第7章 細胞培養市場:各地區的預測

  • 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第8章 競爭情形

  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific, Inc
  • Becton, Dickinson and Company
  • Merck KGAA
  • Sartorius AG
  • VWR International, LLC
  • Eppendorf AG
  • Promocell GmbH
  • EMD Millipore
  • Biospherix
目錄
Product Code: 978-1-68038-536-6

Title:
Cell Culture Market Analysis
By Consumables (Media, Sera, Reagents), By Products (Culture Systems, Incubators, Pipetting Instruments, Centrifuges, Biosafety Equipment, Cryostorage Equipment), By Application (Biopharmaceuticals, Cancer Research, Drug Development, Gene Therapy, Tissue Culture & Engineering, Toxicity Testing, Vaccine Production) And Segment Forecasts To 2022.

The global cell culture market is expected to reach USD 37.0 billion by 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the growing need for biopharmaceutical development, vaccine research and development, and protein production; all of which rely heavily on cytological R&D in which cell culture plays a pivotal role.

The development and commercialization of integrated robotic liquid handling laboratory automation culture systems is also expected to considerably enhance growth over the forecast period. These systems provide highly improved capacity handling, higher efficiency and reproducible purity levels.

Further key findings from the report suggest:

  • Cell culture sera accounted for over 50% of revenue generated in 2014 owing to, high usage rates of serum in the composition of cell cultures and their relatively high average market prices. Furthermore, commercialization of serum free sera is also expected to drive market demand in the coming years.
  • Culture reagents including amino acids, cofactors, thrombin, and growth factors, even though used in trace quantities, account for a considerably large share of revenue owing to their relatively expensive prices.
  • North America accounted for the largest share of this market in 2014, as there are a significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for biopharmaceuticals is also anticipated to fuel regional market growth during the forecast period.
  • Rising demand, for cell culture technology and cell biology research in Europe has shown significant development and companies have started investing in innovative technologies and advances in cell culture applications.
  • Asia Pacific is expected to witness significant growth in demand over the forecast period owing to the presence of high unmet need for increasing production and development of vaccines, drugs, and new biologics. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in biopharmaceutical manufacturing and high untapped market opportunities are some important factors accounting for such rapid growth in demand.
  • Key participants of the cell culture market include Sartorius, Thermo Fisher Scientific, General Electric, Merck, Sigma-Aldrich Co., LLC, Corning, Lonza, Promocell, Becton, Dickinson & Company, and Eppendorf.
  • Market participants are involved in extensive R&D of 3D cell culture and full commercialization of the technologically advanced cell culture which offer higher accuracy of replication, greater purity and rapid growth

Grand View Research has segmented cell culture market on the basis of consumables, products, applications and regions:

Cell Culture Consumables Outlook (Market Revenue in USD Billion, 2012 - 2022 )

  • Media
  • Minimum Essential Media (MEM)
  • RPMI 1640 Media
  • DMEM/F-12 Media
  • F-10 Serum Free Media
  • BME Media
  • Insect Media
  • Other Media
  • Sera
  • Fetal Bovine Serum
  • Other Animals' serum
  • Reagents
  • Albumin
  • Other

Cell Culture Product Outlook (Market Revenue in USD Billion, 2012 - 2022 )

  • Culture Systems
  • Incubators
  • Centrifuges
  • Pipetting Instruments
  • Biosafety Equipment
  • Cryostorage Equipment

Cell Culture Applications Outlook (Market Revenue in USD Billion, 2012 - 2022 )

  • Biopharmaceuticals
  • Cancer Research
  • Drug Development
  • Gene Therapy
  • Tissue Culture & Engineering
  • Toxicity testing
  • Vaccine Production

Cell Culture Regional Outlook (Revenue, USD Million, 2012 - 2022)

  • North America
  • Europe
  • Asia Pacific
  • RoW

Table of Contents

Chapter 1: Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2: Executive Summary

Chapter 3: Cell Culture Industry Outlook

  • 3.1. Market segmentation
  • 3.2. Market size and growth prospects, 2012-2022
  • 3.3. Cell culture market dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Expansion in the scope of cell culture technology
    • 3.3.3. Demand for biopharmaceuticals, artificial organs & vaccine production
    • 3.3.4. Demand for serum-free, specialty and customized media
      • 3.3.4.1. Expansion in the scope of cell culture technology
      • 3.3.4.2. Demand for biopharmaceuticals, artificial organs & vaccine production
      • 3.3.4.3. Demand for serum-free, specialty and customized sera & reagents
    • 3.3.5. Market restraint analysis
      • 3.3.5.1. Stringent process control
      • 3.3.5.2. Scalability issues
      • 3.3.5.3. Ethical concern over use of animals
  • 3.4. Key opportunities prioritized, 2014
  • 3.5. Industry analysis-Porter's
  • 3.6. Cell culture PESTEL Analysis

Chapter 4: Cell Culture Outlook by Consumable

  • 4.1. Global cell culture revenue share, by consumable, 2014 & 2022
  • 4.2. Cell culture sera
    • 4.2.1. Cell culture sera market, 2012-2022(USD Million)
    • 4.2.2. Fetal Bovine Serum
      • 4.2.2.1. Fetal bovine serum market, 2012-2022(USD Million)
    • 4.2.3. Other cell culture sera
      • 4.2.3.1. Other cell culture sera market, 2012-2022(USD Million)
  • 4.3. Cell culture reagents
    • 4.3.1. Cell culture reagents market, 2012-2022(USD Million)
    • 4.3.2. Culture Albumin
      • 4.3.2.1. Culture albumin market, 2012-2022(USD Million)
    • 4.3.3. Other cell culture reagents
      • 4.3.3.1. Other cell culture reagents market, 2012-2022(USD Million)
  • 4.4. Cell culture media
    • 4.4.1. Cell culture media market, 2012-2022(USD Million)
    • 4.4.2. Minimum essential media(MEM)
      • 4.4.2.1. MEM market, 2012-2022(USD Million)
    • 4.4.3. RPMI 1640 media
      • 4.4.3.1. RPMI 1640 media market, 2012-2022(USD Million)
    • 4.4.4. DMEM/F-12 media
      • 4.4.4.1. DMEM/F-12 media market, 2012-2022(USD Million)
    • 4.4.5. F-10 serum-free media
      • 4.4.5.1. F-10 serum-free media market, 2012-2022(USD Million)
    • 4.4.6. Basal medium eagle(BME) media
      • 4.4.6.1. BME media market, 2012-2022(USD Million)
    • 4.4.7. Insect media
      • 4.4.7.1. Insect media market, 2012-2022(USD Million)
    • 4.4.8. Other culture media
      • 4.4.8.1. Other culture media market, 2012-2022(USD Million)

Chapter 5: Cell Culture Product Outlook

  • 5.1. Global cell culture revenue share, by product, 2014 & 2022
  • 5.2. Culture systems
    • 5.2.1. Culture systems market, 2012-2022(USD Million)
  • 5.3. Incubators
    • 5.3.1. Incubators market, 2012-2022(USD Million)
  • 5.4. Centrifuges
    • 5.4.1. Centrifuges market, 2012-2022(USD Million)
  • 5.5. Cryostorage equipment
    • 5.5.1. Cryostorage equipment market, 2012-2022(USD Million)
  • 5.6. Biosafety equipment
    • 5.6.1. Biosafety equipment market, 2012-2022(USD Million)
  • 5.7. Pipetting instruments
    • 5.7.1. Pipetting instruments market, 2012-2022(USD Million)

Chapter 6: Cell Culture Application Outlook

  • 6.1. Global cell culture revenue share, by product, 2014 & 2022
  • 6.2. Biopharmaceuticals
    • 6.2.1. Biopharmaceuticals market, 2012-2022(USD Million)
    • 6.2.2. Tissue culture & engineering
      • 6.2.2.1. Tissue culture & engineering market, 2012-2022(USD Million)
    • 6.2.3. Vaccine production
      • 6.2.3.1. Vaccine production market, 2012-2022(USD Million)
    • 6.2.4. Drug development
      • 6.2.4.1. Drug development market, 2012-2022(USD Million)
    • 6.2.5. Gene therapy
      • 6.2.5.1. Gene therapy market, 2012-2022(USD Million)
    • 6.2.6. Toxicity testing
      • 6.2.6.1. Toxicity testing market, 2012-2022(USD Million)
    • 6.2.7. Cancer research
    • 6.2.8. Cancer research market, 2012-2022(USD Million)

Chapter 7: Cell Culture Regional Outlook

  • 7.1. Cell culture revenue share, by region, 2014 & 2022
  • 7.2. North America
    • 7.2.1. North America cell culture market, 2012-2022(USD Million)
  • 7.3. Europe
    • 7.3.1. Europe cell culture market, 2012-2022(USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific cell culture market, 2012-2022(USD Million)
  • 7.5. RoW
    • 7.5.1. RoW cell culture market, 2012-2022(USD Million)

Chapter 8: Competitive Landscape

  • 8.1. Sigma-Aldrich Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Strategic Initiatives
  • 8.2. Thermo Fisher Scientific, Inc
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Services
    • 8.2.4. Strategic Initiatives
  • 8.3. Becton, Dickinson and Company
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Strategic initiatives
  • 8.4. Merck KGAA
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Strategic Initiatives
  • 8.5. Sartorius AG
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Strategic Initiatives
  • 8.6. VWR International, LLC
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Strategic Initiatives
  • 8.7. Eppendorf AG
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Strategic initiatives
  • 8.8. Promocell GmbH
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Strategic initiatives
  • 8.9. EMD Millipore
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Strategic Initiatives
  • 8.10. Biospherix
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Strategic Initiatives

List of Tables

  • TABLE 1: Cell Culture-Industry Snapshot & Key Buying Criteria, 2012-2022
  • TABLE 2: Global cell culture market, by consumable, 2012-2022 (USD Million)
  • TABLE 3: Global cell culture market, by product, 2012-2022 (USD Million)
  • TABLE 4: Global cell culture market, by application, 2012-2022 (USD Million)
  • TABLE 5: Cell culture market, by region, 2012-2022 (USD Million)
  • TABLE 6: Cell culture market-Key driver analysis
  • TABLE 7: Cell culture market-Key market restraint analysis
  • TABLE 8: North America cell culture market, by consumable, 2012-2022 (USD Million)
  • TABLE 9: North America cell culture media, by type, 2012-2022 (USD Million)
  • TABLE 10: North America cell culture sera, by type, 2012-2022 (USD Million)
  • TABLE 11: North America cell culture reagents, by type, 2012-2022 (USD Million)
  • TABLE 12: North America cell culture market, by product, 2012-2022 (USD Million)
  • TABLE 13: North America cell culture market, by application, 2012-2022 (USD Million)
  • TABLE 14: Europe cell culture market, by consumable, 2012-2022 (USD Million)
  • TABLE 15: Europe cell culture media, by type, 2012-2022 (USD Million)
  • TABLE 16: Europe cell culture sera, by type, 2012-2022 (USD Million)
  • TABLE 17: Europe cell culture reagents, by type, 2012-2022 (USD Million)
  • TABLE 18: Europe cell culture market, by product, 2012-2022 (USD Million)
  • TABLE 19: Europe cell culture market, by application, 2012-2022 (USD Million)
  • TABLE 20: Asia Pacific cell culture market, by consumable, 2012-2022 (USD Million)
  • TABLE 21: Asia Pacific cell culture media, by type, 2012-2022 (USD Million)
  • TABLE 22: Asia Pacific cell culture sera, by type, 2012-2022 (USD Million)
  • TABLE 23: Asia Pacific cell culture reagents, by type, 2012-2022 (USD Million)
  • TABLE 24: Asia Pacific cell culture market, by product, 2012-2022 (USD Million)
  • TABLE 25: Asia Pacific cell culture market, by application, 2012-2022 (USD Million)
  • TABLE 26: RoW cell culture market, by consumable, 2012-2022 (USD Million)
  • TABLE 27: RoW cell culture media, by type, 2012-2022 (USD Million)
  • TABLE 28: RoW cell culture sera, by type, 2012-2022 (USD Million)
  • TABLE 29: RoW cell culture reagents, by type, 2012-2022 (USD Million)
  • TABLE 30: RoW cell culture market, by product, 2012-2022 (USD Million)
  • TABLE 31: RoW cell culture market, by application, 2012-2022 (USD Million)

List of Figures

  • FIG. 1: Cell Culture market segmentation
  • FIG. 2: Global cell culture market, 2012-2022 (USD Million)
  • FIG. 3: Cell culture market dynamics
  • FIG. 4: Key opportunities prioritized
  • FIG. 5: Cell culture market Porter's analysis
  • FIG. 6: Cell culture market PESTEL analysis
  • FIG. 7: Cell culture revenue share, by consumable, 2014 & 2022
  • FIG. 8: Cell culture sera market, 2012-2022 (USD Million)
  • FIG. 9: Fetal bovine serum market, 2012-2022 (USD Million)
  • FIG. 10: Other cell culture sera market, 2012-2022 (USD Million)
  • FIG. 11: Cell culture reagents markets, 2012-2022 (USD Million)
  • FIG. 12: Culture albumin market, 2012-2022 (USD Million)
  • FIG. 13: Other cell culture reagents market, 2012-2022 (USD Million)
  • FIG. 14: Cell culture media market , 2012-2022 (USD Million)
  • FIG. 15: MEM market, 2012-2022 (USD Million)
  • FIG. 16: RPMI 1640 media market, 2012-2022 (USD Million)
  • FIG. 17: DMEM/F-12 media market, 2012-2022 (USD Million)
  • FIG. 18: F-10 serum-free media market, 2012-2022 (USD Million)
  • FIG. 19: BME media market, 2012-2022 (USD Million)
  • FIG. 20: Insect media market, 2012-2022 (USD Million)
  • FIG. 21: Other culture media market, 2012-2022 (USD Million)
  • FIG. 22: Cell culture revenue share, by product, 2014 & 2022
  • FIG. 23: Culture systems market , 2012-2022 (USD Million)
  • FIG. 24: Incubators market , 2012-2022 (USD Million)
  • FIG. 25: Centrifuges market , 2012-2022 (USD Million)
  • FIG. 26: Cryostorage equipment market , 2012-2022 (USD Million)
  • FIG. 27: Biosafety equipment market , 2012-2022 (USD Million)
  • FIG. 28: Pipetting instruments market , 2012-2022 (USD Million)
  • FIG. 29: Cell culture revenue share, by product, 2014 & 2022
  • FIG. 30: Biopharmaceuticals market , 2012-2022 (USD Million)
  • FIG. 31: Tissue culture & engineering market , 2012-2022 (USD Million)
  • FIG. 32: Vaccine production market , 2012-2022 (USD Million)
  • FIG. 33: Drug development market , 2012-2022 (USD Million)
  • FIG. 34: Gene therapy market , 2012-2022 (USD Million)
  • FIG. 35: Toxicity testing market , 2012-2022 (USD Million)
  • FIG. 36: Cancer research market , 2012-2022 (USD Million)
  • FIG. 37: Cell culture market share, by region, 2014 & 2022
  • FIG. 38: North America cell culture market, 2012-2022 (USD Million)
  • FIG. 39: Europe cell culture market, 2012-2022 (USD Million)
  • FIG. 40: Asia Pacific cell culture market, 2012-2022 (USD Million)
  • FIG. 41: RoW cell culture market, 2012-2022 (USD Million)
Back to Top